Amlodipine Besylate Tablets USP recalled over manufacturing violations
- Recall date
- February 19, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Lupin Limited recalls Amlodipine Besylate Tablets USP, 2.5mg, 90-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltim…
- Recall number
- D-1492-2016
- FDA classification
- Class III
- Brand / firm
- Lupin Limited
- Sold / distributed
- US No recalled product was distributed to any foreign consignees by Lupin.
Why it was recalled
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Amlodipine Besylate Tablets USP, 2.5mg, 90-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Goa 403 722 INDIA, NDC 68180-750-09
Get recall alerts
Free email alert whenever Lupin Limited has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Lupin Limited